Icosavax develops safe and effective vaccines against infectious diseases that cause severe, life-threatening respiratory illnesses.

Register for Details

For more details on financing and valuation for Icosavax, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Icosavax's ticker symbol?


What is Icosavax's stock price?

10.23 as of 11/29/23

Learn more about Icosavax

Forge green plus iconForge green minus icon

When was Icosavax founded?

Icosavax was founded in 2017.
Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.